Drug Profile
Research programme: broad-spectrum antifungal - Acea Biotech
Alternative Names: CorifunginLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Acea Biotech
- Class Macrolides; Polyenes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Mycoses in USA
- 15 Sep 2009 Early research in Mycoses in USA (unspecified route)